Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

S-Refit

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 3
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Key employees Soon

Areas of investment

  • Biotechnology
  • SaaS
  • Software
  • Medical
  • Therapeutics
Summary

The company was established in Europe in Germany. The main office of represented VC is situated in the Regensburg.

The high activity for fund was in 2005. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. Among the various public portfolio startups of the fund, we may underline Isarna Therapeutics, Lophius Biosciences

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the S-Refit, startups are often financed by High-Tech Gru00fcnderfonds, Bayern Kapital GmbH, Global Chance Fund. The meaningful sponsors for the fund in investment in the same round are VRD GmbH, MIG AG, Heidelberg Innovation. In the next rounds fund is usually obtained by MIG AG, wolf biotech gmbh, VRD GmbH.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Boulevard Capital Partners California, Los Angeles, United States
Darwin Ventures Burlingame, California, United States
Dick Clark Productions California, Santa Monica, United States
Elwin Capital Partners England, London, United Kingdom
Government of United States of America District of Columbia, United States, Washington
Istithmar Dubai, United Arab Emirates
Kunyu Capital Beijing, Beijing, China
LGL Capital Pty Ltd -
Mandarin Capital Partners Italy, Lombardia, Milano
Picardie Investissement Amiens, France, Picardie
Red Rowant -
Regates y Sainetes -
Seattle Bank -
The Santa Cruz Operation -
TIEC Incubation Al Qahirah, Cairo, Egypt
Tiger Global Mauritius Fund -
ViewPoint Capital Partners Switzerland, Zürich, Zurich
Xizang Langrun Chengguan District, China, Lhasa
Zhongyunhui Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

TM3 Software

SaaS
Software
31 May 2011 Regensburg, Bavaria, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent S-Refit?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 5M
Peak activity year 2011
Lead investments 0
Follow on index 0.25
Group Appearance index 0.75

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

TM3 Software

SaaS
Software
31 May 2011 Regensburg, Bavaria, Germany
Crunchbase icon

Content report

The following text will be sent to our editors: